SL.No Sex Age CNS symptoms Temp
(°C)
Renal damage HB (g/L) Plt ( x109/L) schistocytes (%) LDH ADAMTS13
%
ADAMTS13 inhibitor Previous episodes TTP (N) ANA hospital stay (days)
1 F 38 Yes 38.8 No 53 4 18 947 <5% Yes No + 21
2 F 37 Yes 38.5 No 60 9 7 825 <5% Yes No + 32
3 F 60 Yes 38 No 65 8 10 610 <5% Yes No - 28
4 M 60 Yes 37.9 No 109 9 5 758 <5% Yes No + 37
5 M 70 Yes 36.5 No 78 12 13 1242 <5% Yes No - 39
6 F 48 Yes 36.4 No 71 8 11 1089 <5% Yes No + 17
7 F 25 Yes 37.5 No 87 7 8 1672 <5% Yes No + 26
8 M 45 Yes 36.8 Yes 108 4 1 2031 <5% Yes No + 27
9 M 38 No 39 No 62 5 21 900 <5% Yes No - 10
10 F 35 Yes 36.1 Yes 64 19 2 934 <5% Yes No + 11
11 F 33 Yes 39.5 No 69 15 3 1368 <5% Yes No - 33
12 F 32 Yes 39.7 No 35 2 3 2524 <5% Yes No - 37
13 F 47 Yes 38.6 No 78 18 2 1146 <5% Yes No - 21
14 M 70 Yes 38.3 No 95 3 6 560 <5% Yes Yes (3) - 34
15 M 23 Yes 37.8 Yes 90 10 1 450 <5% Yes Yes (2) + 42
16 F 47 No 37.2 No 84 37 6 1035 <5% Yes No + 34
17 F 51 Yes 36.9 No 80 10 2 796 <5% Yes No - 38
18 F 28 Yes 38.5 No 65 10 2 531 <5% Yes No + 27
19 F 53 Yes 37.2 Yes 89 10 7 735 <5% Yes No + 30
20 F 36 Yes 36.4 No 72 15 5 398 <5% Yes No - 25
21 F 40 No 40 No 110 5 2 534 <5% Yes No - 17
22 M 45 Yes 36.7 No 78 8 3 379 <5% Yes Yes(1) - 35
23 F 22 Yes 38.6 No 43 7 2 893 <5% Yes No - 28
24 F 23 Yes 37 No 104 12 6 1554 <5% Yes No - 23
25 M 39 Yes 41 Yes 97 51 7 1193 <5% Yes No + 39
26 F 34 Yes 36.8 No 54 6 3 621 <5% Yes Yes(2) + 26
27 F 24 Yes 36.9 No 102 13 3 1737 <5% Yes No - 29
CNS: Central Nervous System; HB:  Hemoglobin; Plt: Platelet; LDH: Lactate Dehydrogenase; ANA: Antinuclear Antibodies.
Table 1: Demographics and clinical characteristics of aTTP patients who received rituximab.